No Data
No Data
No Data
No Data
No Data
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
CAMBRIDGE, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational
GlobeNewswireApr 26 04:05
Relay Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational
GlobeNewswireApr 12 04:05
FATE, ALPN and RLAY Are Among After Hour Movers
Seeking AlphaApr 11 05:20
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersRallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at $81.2 million. Vera Therapeutics (NASDAQ:VERA) shares increased by
BenzingaApr 11 04:31
Relay Payments Revs up Sponsorship of Hendrick Motorsports, Enlisting Fan Voting for William Byron's No. 24 Chevrolet Design
Relay will continue using its partnership with Hendrick Motorsports to highlight trucking's impact on our economyATLANTA, March 21, 2024 /PRNewswire/ -- Relay Payments, the fintech company modernizin
PR NewswireMar 21 21:00
Strong Buy Rating for Relay Therapeutics Amid Pipeline Progress and Strategic Direction
TipRanksMar 19 13:38
No Data
No Data